Related Experiment Videos
Synthesis of gelatin microspheres containing interferon
Pharmaceutical Research
|May 1, 1989
Summary
This study shows that cross-linking gelatin microspheres controls their degradation and interferon release. Macrophages efficiently phagocytose these microspheres, leading to sustained drug delivery within cells.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Immunology
Background:
- Gelatin microspheres are promising drug carriers.
- Controlling drug release and degradation is crucial for effective delivery.
- Interferon-alpha has therapeutic applications but requires targeted delivery.
Purpose of the Study:
- To synthesize and characterize gelatin microspheres for drug delivery.
- To investigate the effect of glutaraldehyde cross-linking on microsphere degradation and interferon release.
- To evaluate the interaction of these microspheres with macrophages and their intracellular fate.
Main Methods:
- Synthesis of sub-micron gelatin microspheres via glutaraldehyde cross-linking.
- Degradation studies in collagenase-containing phosphate-buffered saline.
- Interferon-alpha incorporation and release kinetics analysis.
- In vitro phagocytosis assays with macrophages.
Main Results:
- Microsphere degradation rate decreased with increased glutaraldehyde cross-linking.
- High trapping efficiency for interferon-alpha was achieved.
- Cross-linking extent modulated the rate of interferon release.
- Macrophages readily phagocytosed microspheres irrespective of cross-linking.
- Intracellular degradation of microspheres resulted in sustained interferon release.
Conclusions:
- Glutaraldehyde cross-linking offers a tunable method to control gelatin microsphere degradation and drug release kinetics.
- Gelatin microspheres are effectively internalized by macrophages, enabling intracellular drug delivery.
- These findings support the potential of cross-linked gelatin microspheres as a platform for sustained intracellular delivery of interferon-alpha.